Cite
HARVARD Citation
Zangardi, M. et al. (2019). Sacituzumab for the treatment of triple-negative breast cancer: the poster child of future therapy?. Expert opinion on investigational drugs. pp. 107-112. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zangardi, M. et al. (2019). Sacituzumab for the treatment of triple-negative breast cancer: the poster child of future therapy?. Expert opinion on investigational drugs. pp. 107-112. [Online].